UNIDADE LOCAL DE SAUDE DE SAO JOAO, E.P.E.

Their core work

ULSSJ is a major Portuguese public health system centered on Hospital de São João in Porto — one of the country's largest university hospitals — providing both patient care and clinical research at scale. In EU-funded research, they function as a clinical site: recruiting patients, collecting real-world data, and validating diagnostics in a live hospital environment. Their H2020 participation spans two distinct medical domains: pandemic preparedness and clinical response networks, and AI-assisted sleep medicine. This makes them a rare combination of a high-throughput clinical institution with documented experience in both infectious disease trials and digital diagnostic innovation.

What they specialise in

How they've shifted over time

Both H2020 projects were launched within a single year (2020–2021), so the keyword shift reflects two parallel research tracks rather than a long-term strategic pivot. That said, the direction is readable: their first project (EU-RESPONSE, 2020) was driven by the COVID-19 emergency and plugged them into a European infectious disease preparedness network. Their second (SLEEP REVOLUTION, 2021) represents a deliberate move toward chronic disease management using AI and digital tools — a longer-term, technology-intensive commitment. If the pattern holds, ULSSJ is transitioning from reactive emergency research toward proactive, data-driven clinical innovation in areas like sleep medicine.

ULSSJ appears to be building a digital health research track — starting with AI in sleep medicine — which suggests future interest in ML-assisted diagnostics, remote monitoring, and personalized treatment in other chronic conditions.

How they like to work

ULSSJ has participated exclusively as a consortium partner — never as a coordinator — across both projects, indicating they contribute clinical capacity rather than drive research agendas. Both projects placed them inside very large consortia (64 unique partners across 24 countries), typical of large RIA calls where hospitals serve as clinical validation sites. This suggests a reliable, scalable collaborator for projects that need real patient populations and hospital-grade data collection, not a partner seeking to lead.

ULSSJ has built connections with 64 unique consortium partners across 24 countries through just two projects — reflecting the large, multinational character of the RIA consortia they joined. Their network is broadly European with no visible geographic concentration beyond their home country Portugal.

What sets them apart

As one of Portugal's largest university hospitals, ULSSJ brings something most research institutes cannot: direct access to a high-volume patient population in a functioning clinical environment, which is essential for real-world validation of diagnostic tools. Their combination of infectious disease trial experience (EU-RESPONSE) and AI-driven diagnostics work (SLEEP REVOLUTION) is unusual for a Southern European public hospital, signaling genuine research ambition beyond routine clinical care. For consortium builders needing a credible Southern European clinical site with digital health exposure, ULSSJ is a strong candidate.

Highlights from their portfolio

• SLEEP REVOLUTION
  Highest-funded project (€146,215) and the clearest signal of ULSSJ's strategic direction — applying deep learning and AI to sleep disorder diagnostics in a personalized medicine framework.
• EU-RESPONSE
  Long-running project (2020–2026) integrating ULSSJ into a pan-European pandemic preparedness and platform trials network, demonstrating capacity for multi-year, large-consortium clinical research.